Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment

Trial N/A Completed March 7, 2024

Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"

Trial N/A Completed March 7, 2024

Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)

Trial N/A Completed March 7, 2024

Impulse Control Disorder Among Parkinson's Disease Patients

Trial N/A Unknown March 7, 2024

Safety and Efficacy of Liraglutide in Parkinson's Disease

Trial Phase 2 Completed March 6, 2024

Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation

Trial N/A Unknown March 6, 2024

A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Trial Phase 2 Completed March 5, 2024

A Clinical Trial for the Safety and Effect of MRGuided FUS Subthalamotomy for Medication Refractory Parkinson's Disease

Trial N/A Completed March 5, 2024

Algorithm Guided DBS Programming in Parkinson's Patients

Trial N/A Unknown March 5, 2024

Effect of Intermittent Oro-esophageal Tube Feeding on Dysphagic Patients With Parkinson Disease

Trial N/A Withdrawn March 4, 2024

Effect of Dopamine on Specific Processing of Shame and Embarrassment in Parkinson's Disease

Trial N/A Unknown March 4, 2024

Efficacy of Stellate Ganglion Block in Patients With Parkinson's Disease

Trial N/A Withdrawn March 4, 2024

Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease

Trial N/A Unknown March 4, 2024

Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease

Trial N/A Completed March 3, 2024

Treating Bacterial Overgrowth in Parkinson's Disease

Trial Phase 2 Completed Feb. 29, 2024

A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

Trial Phase 1 Withdrawn Feb. 29, 2024

The Effects Of Myofascial Release In Combined With Task-Oriented Circuit Training On Balance And Gait In People With Parkinson's Disease

Trial N/A Unknown Feb. 28, 2024

Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease

Trial N/A Terminated Feb. 27, 2024

Ambroxol as a Treatment for Parkinson's Disease Dementia

Trial Phase 2 Unknown Feb. 27, 2024

Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease

Trial N/A Unknown Feb. 27, 2024